ADVANCED MALIGNANCY
Clinical trials for ADVANCED MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new ADVANCED MALIGNANCY trials appear
Sign up with your email to follow new studies for ADVANCED MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cancer drug ADCX-020 enters first human trials for advanced tumors
Disease control Recruiting nowThis early-phase study tests a new cancer drug, ADCX-020, in about 290 adults with advanced solid tumors that have stopped responding to standard treatments. The drug is an antibody-drug conjugate designed to target and kill cancer cells. The study first finds a safe dose, then t…
Matched conditions: ADVANCED MALIGNANCY
Phase: PHASE1 • Sponsor: Adcytherix SAS • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New cancer drug trial seeks safe dose for advanced tumors
Disease control Recruiting nowThis early-stage study tests a new drug called SHR-7782 in 200 people with advanced cancer that has spread or cannot be removed. The main goals are to find the safest dose and see if the drug can shrink tumors. Participants must have measurable tumors and be healthy enough for tr…
Matched conditions: ADVANCED MALIGNANCY
Phase: PHASE1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC